IBEX 35
10.729,50 -35,50 (-0,33%) Euro Stoxx 50
4.918,09 -18,48 (-0,37%) Dólar/Euro
1,0661 +0,0015 (+0,14%) Petróleo Brent
87,20 +0,09 (+0,10%) Oro
2.406,70 +8,70 (+0,36%) Bitcoin EUR
59.958,01 +1.504,48 (+2,57%)
McKesson Corporation (MCK)
Después del cierre:
McKesson Corporation
6555 State Highway 161
Irving, TX 75039
United States
972 446 4800
https://www.mckesson.com
Sector(es): Healthcare
Sector: Medical Distribution
Empleados a tiempo completo: 45.000
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Brian S. Tyler Ph.D. | CEO & Director | 7,22M | 6,33M | 1967 |
| Mr. Britt J. Vitalone | Executive VP & CFO | 3,04M | 1,1M | 1969 |
| Ms. LeAnn B. Smith | Executive VP & Chief Human Resources Officer | 1,32M | N/A | 1975 |
| Ms. Lori A. Schechter J.D. | Board & Enterprise Risk Advisor | 2,6M | 1,02M | 1962 |
| Mr. Napoleon B. Rutledge Jr. | Senior VP, Controller & Chief Accounting Officer | N/A | N/A | 1972 |
| Mr. Francisco Fraga | Executive VP, Chief Information Officer & Chief Technology Officer | N/A | N/A | 1973 |
| Rachel Rodriguez | Vice President of Investor Relations | N/A | N/A | N/A |
| Ms. Michele Lau | Executive VP & Chief Legal Officer | N/A | N/A | 1977 |
| Mr. Pete Slone | Senior Vice President of Corporate Public Affairs | N/A | N/A | N/A |
| Mr. Kirk Kaminsky | President of The US Pharmaceutical & Specialty Solutions Business | N/A | N/A | N/A |
Descripción
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Gobierno corporativo
El ISS Governance QualityScore de McKesson Corporation, a día 1 de abril de 2024, es 3. Las puntuaciones base son Auditoría: 9; Tablero: 1; Derechos de los accionistas: 4; Compensación: 4.
